Literature DB >> 7530829

Transformation of mouse cells by wild-type mouse c-Src.

P H Lin1, S Shenoy, T Galitski, D Shalloway.   

Abstract

Previous studies in which chicken and human c-Src were overexpressed in chicken and rodent cells have indicated that overexpression of wild-type c-Src can not induce complete neoplastic transformation. However, studies with v-Src mutants have demonstrated that species-specific differences can play a significant role in transforming activity. Here we show that, in contrast to chicken c-Src, overexpressed mouse c-Src can induce significant anchorage-independent growth and tumorigenicity when transfected into NIH3T3 mouse cells. The biochemical cause for this difference is unknown. In particular, the protein-tyrosine kinase activities of chicken and mouse c-Src appear to be similar. This result is consistent with the hypothesis that v-Src-induced transformation results from perturbation of signalling pathways modulated by c-Src and highlights the need for caution in controlling for potential species-specific differences in studies of c-Src function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530829

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Up-regulation of AMP-activated protein kinase in cancer cell lines is mediated through c-Src activation.

Authors:  Sarit Mizrachy-Schwartz; Noam Cohen; Shoshana Klein; Nataly Kravchenko-Balasha; Alexander Levitzki
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

2.  Extracellular domain dependence of PTPalpha transforming activity.

Authors:  Barbara Tremper-Wells; Ross J Resnick; Xinmin Zheng; Leslie J Holsinger; David Shalloway
Journal:  Genes Cells       Date:  2010-06-07       Impact factor: 1.891

3.  Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation.

Authors:  Rotem Karni; Yael Gus; Yuval Dor; Oded Meyuhas; Alexander Levitzki
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.

Authors:  Kelsi Andrade; Jaime Fornetti; Ling Zhao; Scott C Miller; R Lor Randall; Neysi Anderson; Susan E Waltz; Mark McHale; Alana L Welm
Journal:  Sci Transl Med       Date:  2017-01-25       Impact factor: 17.956

5.  Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation.

Authors:  Tsung-Yao Lin; Chiung-Wen Fan; Ming-Chei Maa; Tzeng-Horng Leu
Journal:  Biomedicine (Taipei)       Date:  2015-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.